CICC Capital, the private equity arm of Hong Kong-listed investment bank China International Capital Corporation Limited (CICC), has raised over 1.6 billion yuan ($229 million) for a biomedicine fund, it said in a statement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
